Technology Flashcards
What is precison medicine?
Specialised treatment tailored to indiviual genetics
Biomarker guided indivualised treatment
Why is precision medicine important
- Better patient care today
- Increased potential for today’s research to enhance tomorrow’s patient care
Relationship of precision medicine and research diagram
Lecture Slide
Histopathology
- used to?
- Can identify numerous cell and tissue feature that are informative about health and disease
- Tissue and cell morphology as well as fine details
- Pattern recognition
- Diagnosis, prognosis, direction of treatment
Immunochemistry
-used to?
- Can identify specific proteins in/on cells
- Identifies the state of cells
- Identifies cell type
- Identifies potential treatments
Type of method for DNA sequencing older and newer versions
Sanger Sequencing (older) and Next Generation Sequencing (newer)
Process of Next Generation Sequencing
Genomic DNA
Cut DNA
Add linkers
Input library
Flow cell
In situ PCR
Sequencing
Genome vs exome
Whole Genome is all the genetic material and exome is a slice of that genome.
Scenario: sequencing the KRAS gene to guide targeted therapy
Example: KRAS mutation testing for cetuximab in metastatic colorectal cancer
- KRAS is activated by? what does it cause?
- What is used to prevent KRAS
Epidermal growth Factor acts on EGFR causing KRAS activation leading to enhanced proliferation and survvial of cells
Cetuximab stops EGF binding to EGFR and thus reducing proliferation and survival
What happens if there is a mutation of KRAS gene
-type of cancer is related to
Epithelial ovarian cancer
If there is a mutation of KRAS gene, this means it is no longer reliant on EGF binding to EGFR causing activation. THEREFORE KRAS doesnt need EGFR activation to cause
cell proliferation, so the drug (Cetuximab) has no effect leading to enhanced proliferation and survival
AI in medicine
- examples
-why isnt it used more
- Cancer detection using gigapixal
- AI on reading Xrays
- Technological limitations remain but can be overcome
- Our incomplete molecular understanding of disease is now the major limitation to realising the value of research using genomics and bioinformatics
- Technology is waiting for our scientific understanding to catch up – ongoing research is key
- Untneable Inequity